Position: |
Finance & Accounting, Controller (Sr Director/Executive Director/VP) |
Department: |
Finance and Accounting |
Location: |
Remote (PST Zone) with regular travel to Los Angeles office and periodic travel to Guangzhou, China office |
Reports To: |
CFO |
Position Summary
The Finance & Accounting, Controller will play a critical role in the Company’s strategic financial leadership, preparing for IPO readiness initiatives, developing financial controls in anticipation of future Sarbanes-Oxley (SOX) compliance in a highly regulated environment, conversion from IFRS to GAAP accounting standards, transitioning to US-led financial audits, leading budgeting process and strengthening the Company’s financial planning and analysis (FP&A) capabilities. This position will partner closely with stakeholders to oversee the financial strategy and planning, manage risk, and optimize financial operations.
Responsibilities
Qualifications
Salary Range:
$200,000 - $300,000
About Angitia
Established in June 2018, Angitia Biopharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases. Angitia is currently studying 3 biologic product candidates in the clinic for the treatment of osteoporosis (Phase 2), osteogenesis imperfecta (OI) (Phase 1), and spinal fusion (Phase 3). Leveraging the team's extensive experience and scientific acumen in novel drug development, Angitia is committed to providing groundbreaking therapies to satisfy key unmet medical needs. The founder and the core team members of Angitia are seasoned scientific leaders in new drug discovery, development, and management from both overseas and domestic large multinational companies. The company has built an organization with offices in Woodland Hills, CA and Guangzhou, China that is distinguished by world-class scientists with talents that are proficient in the pathophysiology of musculoskeletal diseases. We utilize cutting-edge technologies of genetics and molecular biology to uncover new mechanisms, signal transduction pathways and their interactions combined with computer aided drug design to identify new drug targets, and to discover and develop new biological and small molecule medicines. The company is committed to serving patients in need by carrying out innovative science including internal research and external collaborations with academics and global biopharmaceutical companies. We are seeking talented individuals who are innovative, ambitious, and great team players to join our vibrant group.
Learn more at www.angitiabio.com.
Benefits:
Nielsen
EthosEnergy
Gatekeeper
SAGAN
SDL Search Partners